Santhera raises EUR 16 million

Santhera (Basel, Switzerland) raised EUR 16 million ($19.2 million) in the third closing of a series B round, bringing the round's total to EUR 30 million ($36 million). Investors included NGN Capital; Oxford Bioscience Partners; Varuma; Merlin Biosciences; 3i Group; Carnegie Asset Management; GIMV; the Novartis Venture Fund; Dow (DOW); Clariden Biotechnology Fund; Heidelberg Innovation; and the Swiss Foundation for Research on Muscle Diseases. ...